成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Biomedicine & Pharmacotherapy >>article
Biomedicine & Pharmacotherapy

Biomedicine & Pharmacotherapy

IF: 6.9
Download PDF

Role of ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation

Published:1 December 2022 DOI: 10.1016/j.biopha.2022.113912
Sun Xiaodan , Cheng Ying

Abstract

Ginsenoside Rh2 (Rh2), the major bio-active ginsenoside that originated from the root of Panax ginseng, has become a “hot topic” for playing multifunctional roles in both tumor treatment and tumor microenvironment (TME) immunomodulation. Up to now, emerging experimental research about Rh2 in tumor therapy and immuno-regulation has been published, however, the specific reviews focused on its role in the TME were limited. Hence, in this article, we briefly summarized existing evidence supporting the anticancer effects and potential mechanisms of Rh2 according to the tumor type, including anti-proliferation, anti-invasion, and metastasis, induction of cell cycle arrest, anti-angiogenesis, promotion of reactive oxygen species and differentiation. Meanwhile, we shed light on the role of Rh2 in TME, with an emphasis on regulating tumor immunogenicity, immune cells, cytokines, and physicochemical properties of TME. Finally, the current research limitation and prospects of Rh2 were discussed.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Ginsenoside Rh2 78214-33-2 C36H62O8 273 suppliers $39.00-$5330.00
Panax Ginseng extract 50647-08-0 C42H66O17 122 suppliers $482.00-$1200.00

Similar articles

IF:40.8

Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors

Signal Transduction and Targeted Therapy Zhu, Chaojie,etc Published: 22 November 2024
IF:6.1

Systemic tumor regression with synergy therapy: radiotherapy and CAR-T

Cell Death Discovery Ma, Xingyu,etc Published: 22 November 2024
IF:5.7

The transdermal cream of Formestane anti-breast cancer by controlling PI3K-Akt pathway and the tumor immune microenvironment.

Frontiers in Immunology Lanyang Gao, Lei Zhu,etc Published: 1 January 2023